Biogen Idec appoints senior-vice president of gene therapy
This article was originally published in Scrip
Executive Summary
Biogen Idec has appointed Dr Oliver Danos senior vice-president of gene therapy. Dr Danos will report to Dr Douglas Williams, executive vice-president of research and development, and is a member of Biogen Idec's senior research and development leadership team. Dr Danos joins Biogen Idec from Kadmon Pharmaceuticals, where he had served as senior vice-president of molecular medicine, synthetic biology and gene regulation since 2011.